Catalyst Tracker
EnGene Holdings ENGN results announcement
EnGene Holdings gave investors an update to their Phase 1/2 trial for EG-70 - (LEGEND). Our analysts summarized the update as follows:
"Phase 1/2 ongoing."
The market reacted positively, but roughly in line with how [...]
Read MoreGH Research PLC GHRS earnings announcement
GH Research PLC revealed their most recent quarterly earnings data, in which EPS ended up higher than estimates. EPS was estimated to be -$0.22 and the actual figure came in at -$0.15. GH Research PLC's [...]
Read MoreAeterna Zentaris HOWL earnings announcement
Werewolf Therapeutics revealed their most recent quarterly earnings data, in which both revenue and EPS ended up lower than estimates. The revenue estimate was $1.82M, but the actual figure was $742k. Werewolf Therapeutics' revenue [...]
Read MoreDyne Therapeutics DYN earnings announcement
Dyne Therapeutics revealed their most recent quarterly earnings data for Q1. EPS was reported to be -$0.81, which fell in line with the estimated value of -$0.80. Dyne Therapeutics' EPS is now [...]
Read MoreCardiff Oncology CRDF earnings announcement
Cardiff Oncology revealed their most recent quarterly earnings data, in which both revenue and EPS ended up higher than estimates. Revenue, at $205k, was the biggest surprise for the quarter, as it exceeded [...]
Read MoreCardiff Oncology VIR earnings announcement
Vir Biotechnology revealed their most recent quarterly earnings data, in which EPS ended up higher than estimates. EPS was estimated to be -$1.05 and the actual figure came in at -$0.48. Vir Biotechnology's EPS is [...]
Read MoreAeterna Zentaris KURA earnings announcement
Kura Oncology revealed their most recent quarterly earnings data, in which EPS ended up lower than estimates. EPS was reported to be -$0.59, which fell short of the estimated value of -$0.55. Kura [...]
Read MoreCardiff Oncology PBYI earnings announcement
Puma Biotechnology revealed their most recent quarterly earnings data, in which both revenue and EPS ended up higher than estimates. EPS, at -$0.05, was the biggest surprise for the quarter, as it exceeded [...]
Read MoreBiomea Fusion BMEA earnings announcement
Biomea Fusion revealed their most recent quarterly earnings data, in which EPS ended up lower than estimates. EPS was reported to be -$1.09, which fell short of the estimated value of -$0.99. That [...]
Read MoreAeterna Zentaris RLAY earnings announcement
Relay Therapeutics revealed their most recent quarterly earnings data, in which both revenue and EPS ended up higher than estimates. Revenue, at $10.01M, was the biggest surprise for the quarter, as it exceeded [...]
Read More